iBio announced that its Board of Directors has approved a 20-to-1 reverse split of the company’s common stock, par value $0.001 per share effective at 12:01 a.m. ET on November 29. The common stock is expected to begin trading on a split-adjusted basis when the market opens on November 29, 2023, with the new CUSIP number 451033708.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IBIO:
- iBio Announces Reverse Stock Split
- iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific
- iBio further expands its AI-powered tech stack with launch of ShieldTx
- iBio files to sell common stock, warrants, no amount given
- iBio to highlight technology for advancing discovery of bispecifics
